Portfolio Lab

Johnson & Johnson

  • Stock
  • Ticker JNJ
  • ISIN US4781601046
  • NYSE

Health care · Pharmaceuticals · USA

$270.47 +1.25%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Johnson & Johnson since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

JNJGlobal equities (VT)

$10,000 grew to $30,648. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −27.4% in 03/2020, measured from the peak in 02/2020. It took 3 months to get back to the old peak.

1-year return
+36.2%
5-year return p.a.
+13.8%
10-year return p.a.
+11.9%
Volatility p.a.
17.2%
Largest decline
−27.4%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue22,52021,89323,74323,99324,56424,06225,31025,399
Gross profit15,39214,53616,11516,69016,59615,95617,25917,302
Net income3,43110,9995,5375,1525,1165,2355,534210
Earnings per share1.414.542.292.122.092.142.270.09
Balance sheet
Total assets180,104193,671193,389192,816199,210200,894201,061197,425
Liabilities108,614115,562114,916113,539117,666119,708116,090115,896
Equity71,49078,10978,47379,27781,54481,18684,97181,529
Cash24,10538,47418,57718,23119,70921,68820,42216,910
Long-term debt30,65138,35539,23539,40839,43837,52737,34435,799
Cash flow
Operating cash flow6,9834,1743,8789,1697,3092,5148,6167,720
Capital expenditure-1,612-795-1,043-1,157-1,837-1,049-1,321-1,362
Free cash flow5,3713,3792,8358,0125,4721,4657,2956,358

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2025 at +47.5%, weakest 2023 at −8.6%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
21 Oct 2026$0.09
23 Jul 2026$2.27
22 Apr 2026$2.14
11 Feb 2026$2.09
22 Oct 2025$2.12
24 Jul 2025$2.29
23 Apr 2025$4.54
13 Feb 2025$1.41
23 Oct 2024$1.11
25 Jul 2024$1.93
1 May 2024$1.34
16 Feb 2024$1.67

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€590bn
Market cap in trading currency
$651bn
Enterprise value
$679bn
P/E
41.0
P/S
6.55
P/B
7.99
EV/Sales
6.83
EV/EBITDA
25.3
Earnings yield
2.4%
FCF yield
3.2%

Results (last four quarters)

Revenue
$99.3bn
Gross profit
$67.1bn
EBITDA
$26.8bn
Net income
$16.1bn
Earnings per share
$6.59
Revenue per share
$41.26
Revenue growth
+5.9%
Earnings growth
−95.9%

Profitability

Gross margin
67.6%
Operating margin
18.8%
Net margin
16.2%
Return on equity
20.0%
Return on assets
8.2%

Balance sheet and cash flow

Cash
$17.2bn
Cash per share
$7.16
Financial debt
$44.7bn
Debt/equity %
55
Current ratio
1.02
Book value per share
$33.87
Operating cash flow
$26.2bn
Free cash flow
$20.6bn

Dividend

Dividend yield
1.95%
Dividend (12 months)
$5.28
Yield (12 months)
1.95%
Payout ratio
80%
Ex-dividend date
25 Aug 2026

Shares and trading

Shares outstanding
2.41bn
Volume
11.9m
Avg. volume 3 months
7.12m
Relative volume
1.7

Price and technicals

Price
$270.47
1 day
+1.2%
52-week high
$285.75
52-week low
$199.96
Distance to 52-week high
−5.3%
Distance to 52-week low
+35.3%
Distance to 50-day line
+1.1%
Distance to 200-day line
+7.8%
RSI (14)
48
Volatility 1M
24.9%

Performance

1 week
−5.3%
1 month
+1.1%
3 months
−0.9%
6 months
+15.4%
YTD
+30.7%
1 year
+33.6%

Dates

Fiscal year end
28 Dec 2025
Most recent quarter
27 Sep 2026

Frequently asked questions

How has JNJ performed since 11/2016?

$10,000 grew to $30,648 by 20 Nov 2026, which is +11.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is JNJ?

Volatility was 17.2% per year, measured on monthly returns. The largest decline from a peak was −27.4%, with the low in 03/2020.

How does JNJ compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, JNJ returned +11.9% at 17.2%. The correlation of monthly returns was 0.42; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Johnson & Johnson (JNJ): Return and risk | Portfolio Lab